|
Saio, Masanao; Teicher, Matt; Campbell, Gaynor et al. (2004) Immunocytochemical demonstration of down regulation of HLA class-I molecule expression in human metastatic breast carcinoma. Clin Exp Metastasis 21:243-9
|
|
Lee, C K; Rao, D T; Gertner, R et al. (2000) Distinct requirements for IFNs and STAT1 in NK cell function. J Immunol 165:3571-7
|
|
Radoja, S; Frey, A B (2000) Cancer-induced defective cytotoxic T lymphocyte effector function: another mechanism how antigenic tumors escape immune-mediated killing. Mol Med 6:465-79
|
|
Rao, T D; Frey, A B (1998) Administration of silica sensitizes lipopolysaccharide responsiveness of murine macrophages but inhibits T and B cell priming by inhibition of antigen presenting function. Immunol Invest 27:181-99
|
|
Frey, A B (1997) Study of immune response to tumors in the rat. Methods 12:173-88
|
|
Frey, A B; Cestari, S (1997) Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules. Cell Immunol 178:79-90
|
|
Appleman, L J; Frey, A B (1996) Tumors antigens encoded by oncogenes and the impact of oncogenes upon the immune responses. Cell Immunol 170:1-10
|
|
Frey, A B (1996) Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762. J Immunol 156:3841-9
|
|
Frey, A B (1995) Rat mammary adenocarcinoma 13762 expressing IFN-gamma elicits antitumor CD4+ MHC class II-restricted T cells that are cytolytic in vitro and tumoricidal in vivo. J Immunol 154:4613-22
|
|
Frey, A B; Cestari, S (1995) Expression of activated H-rasval12 in nontumorigenic and non-cross-reactive syngeneic cells induces tumor antigens cross-reactive with rat mammary adenocarcinoma 13762. J Immunol 155:4783-9
|
Showing the most recent 10 out of 11 publications
